Masafumi Funamoto

1.0k total citations
61 papers, 732 citations indexed

About

Masafumi Funamoto is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Molecular Medicine. According to data from OpenAlex, Masafumi Funamoto has authored 61 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Cardiology and Cardiovascular Medicine and 12 papers in Molecular Medicine. Recurrent topics in Masafumi Funamoto's work include Curcumin's Biomedical Applications (12 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac Fibrosis and Remodeling (7 papers). Masafumi Funamoto is often cited by papers focused on Curcumin's Biomedical Applications (12 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac Fibrosis and Remodeling (7 papers). Masafumi Funamoto collaborates with scholars based in Japan, United States and Austria. Masafumi Funamoto's co-authors include Yasufumi Katanasaka, Yoichi Sunagawa, Tatsuya Morimoto, Koji Hasegawa, Yusuke Miyazaki, Hiromichi Wada, Kana Shimizu, Satoshi Shimizu, Hideaki Kakeya and Maki Komiyama and has published in prestigious journals such as Circulation, Nature Communications and Scientific Reports.

In The Last Decade

Masafumi Funamoto

54 papers receiving 719 citations

Peers

Masafumi Funamoto
Comparison fields: 5 of 94
  • Molecular Biology 313
  • Molecular Medicine 236
  • Cardiology and Cardiovascular Medicine 127
  • Physiology 121
  • Pharmacology 65
Yusuke Miyazaki Japan
Paul-Mihai Boarescu Romania
Maral Amini Iran
Laila M. Fadda Saudi Arabia
Ebrahim Sahebi Iran
Sun‐Oh Jeong South Korea
Madhu Dikshit India
Supeenun Unchern Thailand
Nejat Kheiripour Iran
Shahanas Chathoth Saudi Arabia
Yusuke Miyazaki Japan View profile →
Citations per field, relative to Masafumi Funamoto
Masafumi Funamoto · 1×
Citations per year, relative to Masafumi Funamoto
Masafumi Funamoto · 1×

Countries citing papers authored by Masafumi Funamoto

Since Specialization
Citations

This map shows the geographic impact of Masafumi Funamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Funamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Funamoto more than expected).

Fields of papers citing papers by Masafumi Funamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Funamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Funamoto. The network helps show where Masafumi Funamoto may publish in the future.

Co-authorship network of co-authors of Masafumi Funamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Funamoto. A scholar is included among the top collaborators of Masafumi Funamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Funamoto. Masafumi Funamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Deletion of H-ferritin in macrophages mitigates the development of steatohepatitis and hepatocellular carcinoma in mice American Journal of Physiology-Gastrointestinal and Liver Physiology Yasumasa Ikeda, Masafumi Funamoto et al. 0
2 Goreisan suppresses cardiac remodeling and dysfunction in a new mouse model with diabetic cardiomyopathy Journal of Pharmacological Sciences Masafumi Funamoto, Shunji Hirose et al. 0
3 Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan European Heart Journal Open Maki Komiyama, Yuka Ozaki et al. 6
4 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure Nutrients Yoichi Sunagawa, Kana Shimizu et al. 8
5 CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses Journal of Pharmacological Sciences Masaki Imanishi, Keijo Fukushima et al. 4
6 Roles of histone acetylation sites in cardiac hypertrophy and heart failure Frontiers in Cardiovascular Medicine Masafumi Funamoto, Masaki Imanishi et al. 22
7 ANGPTL4 Expression Is Increased in Epicardial Adipose Tissue of Patients with Coronary Artery Disease Journal of Clinical Medicine Yasufumi Katanasaka, Ayumi Saito et al. 11
8 Ecklonia stolonifera Okamura Extract Suppresses Myocardial Infarction-Induced Left Ventricular Systolic Dysfunction by Inhibiting p300-HAT Activity Nutrients Yoichi Sunagawa, Masafumi Funamoto et al. 8
9 Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis Cancers Masaya Ono, Yoichi Sunagawa et al. 6
10 Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex Pharmaceutics Masafumi Funamoto, Yoichi Sunagawa et al. 6
11 The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2–GATA4 Signaling Pathway Pharmaceuticals Kana Shimizu, Yoichi Sunagawa et al. 4
12 Histone Acetylation Domains Are Differentially Induced during Development of Heart Failure in Dahl Salt-Sensitive Rats International Journal of Molecular Sciences Masafumi Funamoto, Yoichi Sunagawa et al. 20
13 Neutrophil/lymphocyte ratio is correlated with levels of inflammatory markers and is significantly reduced by smoking cessation Journal of International Medical Research Maki Komiyama, Yuka Ozaki et al. 11
14 Effect of Theaflavin on Oral Bacteria in Japanese Subjects: A Randomized, Placebo-Controlled, Double-Blind Study Journal of Medicinal Food Yasufumi Katanasaka, Naoki Yoshida et al. 3
15 Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis Phytomedicine Yasufumi Katanasaka, Yoichi Sunagawa et al. 8
16 The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice Scientific Reports Kana Shimizu, Yoichi Sunagawa et al. 34
17 Curcumin Analogue GO-Y030 Significantly Improves Pressure Overload-induced Heart Failure in Vivo European Cardiology Review Kana Shimizu, Masafumi Funamoto et al. 2
18 Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexes International Journal of Cardiology Yusuke Miyazaki, Yasufumi Katanasaka et al. 3
19 Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD International Journal of COPD Tatsuya Morimoto, Masafumi Funamoto et al. 70
20 Optimal Dose-Setting Study of Curcumin for Improvement of Left Ventricular Systolic Function After Myocardial Infarction in Rats Journal of Pharmacological Sciences Yoichi Sunagawa, Yasufumi Katanasaka et al. 30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026